The first personalized CRISPR therapy was delivered to an infant in February 2025. What this means for your child's eligibility.
Compare CMA and WGS for autism, cerebral palsy, and developmental delays - costs, diagnostic yields, and when to use each test.
Which genetic tests to consider, what they cost, expected diagnostic yields, and when testing is recommended after diagnosis.
St. Jude's study shows genome sequencing may lead to better cancer treatments, aiming to sequence 600 pediatric cancer genomes.
Study: Children of parents over 35 have higher autism risk; same risk with one or both older parents.
New gene studies suggest mutations in sperm linked to protein coding may contribute to autism, particularly with older or male parents.
Genetic counseling helps families understand their child's condition, recurrence risks, and available testing options after diagnosis.
Polygenic risk scores estimate autism probability, but they don't diagnose or guide treatment. Here's what they mean.
Chromosomal microarray identifies chromosome disorders in 10% of children with autism. What CMA can and can't find.
Whole genome sequencing finds genetic variants in approximately one-third of autism cases, offering answers when other tests don't.